Literature DB >> 7262160

Use of serial carcinoembryonic antigen assays in detecting relapses in breast cancer involving high risk of metastasis.

J F Chatal, F Chupin, G Ricolleau, J L Tellier, A le Mevel, P Fumoleau, O Godin, B P le Mevel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 7262160     DOI： 10.1016/0014-2964(81)90041-4

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN： 0014-2964            Impact factor:   9.162


× No keyword cloud information.
  4 in total

1.  Monitoring serum CEA in women with primary breast tumours positive for oestrogen receptor and with spread to lymph nodes.

Authors:  J C van der Linden; J P Baak; T Postma; J Lindeman; C J Meyer
Journal:  J Clin Pathol       Date:  1985-11       Impact factor: 3.411

2.  Placental isoferritin (PLF) in comparison with MCA and CEA in advanced breast cancer--first data from a pilot study.

Authors:  M Stierer; H R Rosen; E Forster; C Moroz
Journal:  Breast Cancer Res Treat       Date:  1991-11       Impact factor: 4.872

3.  Use of serial carcinoembryonic antigen and CA 15.3 assays in detecting relapses in breast cancer patients.

Authors:  R Molina; G Zanón; X Filella; F Moreno; J Jo; M Daniels; M L Latre; N Giménez; J Pahisa; M Velasco
Journal:  Breast Cancer Res Treat       Date:  1995       Impact factor: 4.872

4.  Utility of C-erbB-2 in tissue and in serum in the early diagnosis of recurrence in breast cancer patients: comparison with carcinoembryonic antigen and CA 15.3.

Authors:  R Molina; J Jo; G Zanón; X Filella; B Farrus; M Muñoz; M L Latre; J Pahisa; M Velasco; P Fernandez; J Estapé; A M Ballesta
Journal:  Br J Cancer       Date:  1996-10       Impact factor: 7.640
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.